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Characterization and Genetic Manipulation
of Peptide Synthetases in Pseudomonas aeruginosa
PAO1 in Order to Generate Novel Pyoverdines
Domains within each NRPS module provide active sites
for the recognition and adenylation activation of a sub-
strate amino acid (adenylation, or A, domains); transfer
of this activated intermediate to a phosphopantetheinyl
cofactor (bound by a thiolation, or T, domain); and pep-
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New Zealand tide bond formation (catalysed by a condensation, or
C, domain), so that the activated residue is incorporated
into the growing peptide chain. Usually, the final module
in a multienzyme complex also has a thioesterase (TE)Summary
domain that cleaves the nascent peptide from this ter-
minal NRPS and may also be required for catalysis ofPvdD, a nonribosomal peptide synthetase (NRPS) of
Pseudomonas aeruginosa PAO1, incorporates two internal cyclization reactions [12]. We have characterized a
pyoverdine peptide synthetase from P. aeruginosa PAO1,L-threonines into the siderophore pyoverdine. A pvdD
mutant did not synthesize pyoverdine and lacked a PvdD, that is a bimodular enzyme containing each of
these domain types [5]. PvdD catalyses incorporationhigh Mr iron-regulated cytoplasmic protein (IRCP).
Analysis of other IRCPs and the P. aeruginosa genome of two L-threonine residues at the C terminus of the
pyoverdine peptide (Figure 1B). Other pyoverdine pep-enabled the remaining pyoverdine NRPSs to be identi-
fied. The pvdD mutation could be complemented in tide synthetases have been characterized using muta-
tional and bioinformatic approaches [6–9].trans, enabling design of plasmid-based systems for
the generation of novel pyoverdines. Introduction of a The semiautonomous activity of individual domains
within a module and of individual modules within a multi-truncated pvdD gene resulted in attenuated forms of
pyoverdine, and introduction of L-threonine-incorpo- enzyme complex offers potential for the rational alter-
ation of peptide products by manipulation of NRPSs. Ofrating NRPSs from other organisms restored pyover-
dine production to mutant cells. This is the first suc- particular interest is the potential for engineering novel
antibiotics and other secondary metabolites with indus-cessful rational in vivo modification of NRPS modules
outside of Bacillus subtilis. The systems employed did trial applications. To date, attempts to synthesize novel
compounds by NRPS domain or module swapping havenot allow incorporation of other residues into pyover-
dine, indicating that there are multiple elements con- met with only limited success. Novel AT domain regions
have been introduced into the seventh and secondtributing toward substrate specificity in NRPSs.
modules, respectively, of the Bacillus subtilis surfactin
synthetase NRPS multienzyme complex [13, 14]. TheseIntroduction
experiments resulted in the synthesis of novel surfac-
tins that contained the anticipated single residue alter-Fluorescent pseudomonads survive iron limitation by
secreting pyoverdines, mixed hydroxamate-catecholate ations. However, surfactin biosynthesis was signifi-
cantly reduced relative to wild-type. Much higher levelssiderophores that sequester iron from the environment
and are then taken up by the bacteria by specific recep- of recombinant surfactin production were obtained
when a module from the lichenysin synthetases of Bacil-tors [1, 2]. The pyoverdine secreted by P. aeruginosa
strain PAO1 can also act as a signaling molecule that lus licheniformis was introduced into highly homologous
modules of the B. subtilis surfactin synthetase complexregulates gene expression in the bacteria [3]. A large
number of pyoverdines have been characterized, and [15]. The novel multienzyme complex had a Glu-Gln al-
teration in substrate specificity and generated the pre-all consist of an invariant chromophore joined to an acyl
(carboxylic acid or amide) group and a short (6 to 12 dicted novel surfactin product. Lichenysin and surfactin
are structurally similar, and this may have contributedamino acid) type-specific peptide (reviewed in [4]). The
to the success of this module swapping experiment.pyoverdine secreted by P. aeruginosa PAO1 is shown
Other rationally modified surfactins have been ob-in Figure 1A.
tained by relocation of the TE domain [16, 17] and byThe pyoverdine peptide and chromophore are thought
module deletion [18, 19]. However, to date, rational mod-to be derived from amino acid precursors that are as-
ification of NRPS modules in vivo has been confinedsembled by nonribosomal peptide synthetases (NRPSs)
to a single model system: the surfactin synthetases ofwith other enzymes catalyzing additional reactions to
B. subtilis. In this study, we describe manipulation ofcomplete the mature pyoverdines [5–10]. NRPSs are
the pvdD gene of P. aeruginosa in order to generatemultimodular enzymes, with each module governing the
novel pyoverdines.insertion of a single amino acid into the peptide product.
This process is defined by the multiple carrier model
Results[11], which describes a coordinated stepwise series of
amino- to carboxyl-terminal transpeptidation reactions.
Generation and Characterization of a P. aeruginosa
PAO1 pvdD Mutant*Correspondence: iain.lamont@stonebow.otago.ac.nz
A pvdD deletion mutant was generated in which the1Present address: Department of Microbiology and Immunology,
Stanford University, Stanford, California 94305. wild-type gene was replaced with a mutant copy lacking
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Figure 1. Pyoverdine and PvdD
(A) Pyoverdine Pa from P. aeruginosa PAO1
complexed with ferric iron [44]. L-FHOrn, L-N5-
formyl-N5-hydroxyornithine; D-Ser, D-serine;
L-arg, L-arginine; L-lys, L-lysine; L-thr, L-thre-
onine; Chr, chromophore.
(B) The domain structure of PvdD. The mod-
ules are defined by the CAT domain repeats,
and the second module also contains a thio-
esterase domain. The arrows indicate the
L-Thr residues incorporated by each module.
The black triangles indicate insertion points
for domain swapping experiments conducted
in this study.
6.5 kb of the 7.3 kb gene. The identity of the mutant mately 550, 480, 290, and 250 kDa were observed for the
wild-type as reported previously, but the pvdD mutantwas confirmed by Southern blotting (data not shown).
Unlike wild-type P. aeruginosa, the pvdD mutant did not lacked the protein of approximately 290 kDa (Figure 3).
This is consistent with the 273 kDa size of PvdD thatsecrete pyoverdine on agar (Figure 2A; Table 1) or in
liquid culture (Figure 2B). Like other pvd mutants [6], was predicted from sequence data [20]. The presence
of plasmid pPVDD1 that carries the cloned pvdD genebut unlike wild-type P. aeruginosa, the pvdD mutant
strain was unable to grow when the iron-chelating com- restored the 290 kDa IRCP to the pvdD mutant and
increased the amounts of this protein in wild-type bacte-pound ethylene-diamine-di(o-hydroxyphenylacetic acid)
(EDDA) was included in the growth medium (Table 1). ria (Figure 3), showing that the 290 kDa IRCP is indeed
PvdD. These findings confirm that at least one of theThe pvdD mutant was able to utilize exogenous pyover-
dine to grow on agar containing EDDA, indicating that IRCPs is a peptide synthetase that is required for pyover-
dine synthesis.uptake of ferripyoverdine was not affected (Figure 2C).
The P. aeruginosa PAO genome contains two open
reading frames, pvdI (PA2400) and pvdJ (PA2402), im-PvdD Is an IRCP
Large (180–600 kDa) iron-regulated cytoplasmic pro- mediately upstream of pvdD (PA2399), which encode
probable peptide synthetases that are required for pyover-teins (IRCPs) that are made by fluorescent pseudomo-
nads have been identified and are proposed to be pep- dine synthesis [6, 8, 9]. pvdI and pvdJ encode proteins
of 568 kDa and 240 kDa, respectively, that are likely totide synthetases that contribute to pyoverdine synthesis
[10]. IRCPs were prepared from the P. aeruginosa pvdD correspond to the IRCPs of approximately 550 kDa and
250 kDa (Figure 3). On the basis of colinearity (definedmutant and wild-type bacteria. IRCP bands of approxi-
Table 1. Fluorescence and Growth of Modified P. aeruginosa Strains
Growth on KB
Strainb Gene Expressed Fluorescencea Agar  EDDA
Wild-type NA  yes
pvdD mutant NA – no
pvdD(pPVDD1) pvdD high copy number  yes
pvdD(pPVDD2) pvdD low copy number  yes
Wild-type (pPVDD1) pvdD high copy number  yes
Wild-type (pPVDD2) pvdD low copy number  yes
pvdD(pMOD1) pvdD module 1 – no
pvdD(pMOD2) pvdD module 2  no
pvdD(pMOD1, pMOD2) pvdD modules 1 and 2  limited
pvdD(pDAX12) pvdD A swap control  yes
pvdD(pDAX12::syrB-A) pvdD syrB Adom  yes
pvdD(pDAX12::snbC-A) pvdD snbC Adom  yes
pvdD(pDAX13) pvdD CA swap control  yes
pvdD(other pDAX12/13) other swap constructs – no
a The “” signs indicate fluorescence on King’s B agar following overnight growth; the number of  signs indicates the intensity relative to
wild-type, with “” indicating maximal fluorescence and “–” indicating no detectable fluorescence (see Figures 2 and 5).
b The bacterial strain (wild-type P. aeruginosa PAO1 or P. aeruginosa pvdD) and plasmids that are present are listed.
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Figure 2. Phenotype of the pvdD Mutant
(A) Wild-type and pvdD mutant cells grown
on iron-limiting King’s B agar, viewed under
UV light. The mutant cells lack the character-
istic fluorescence conferred by pyoverdine
secretion.
(B) Scanning spectrophotometric traces of
wild-type and pvdD mutant King’s B culture
supernatant, as described in Experimental
Procedures. The pyoverdine present in the
wild-type supernatant has an absorbance
maximum of 403 nm.
(C) pvdD mutant cells streaked near wild-type
on King’s B agar containing the iron-chelating
agent EDDA are only able to grow within the
pyoverdine-containing zone around these
cells, indicating that they are able to utilize,
but not synthesize, pyoverdine.
in [21, 22]), the pvdI gene is predicted to encode the Substrate binding interactions predicted from tertiary
structural models, as previously described for PvdD [5]synthetase modules that incorporate (in order) D-serine,
L-arginine, D-serine, and L-N5-formyl-N5-hydroxyorni- and PvdL [7], were also consistent with the colinear
substrate assignation (data not shown).thine, while the product of the pvdJ gene is predicted
to direct incorporation of L-lysine and L-N5-formyl-N5- A further likely pyoverdine peptide synthetase en-
coded by the pvdL gene (PA2424) is a protein of 479hydroxyornithine [8] (Figure 3). Consistent with this pos-
sibility, sequence analysis shows that the first and the kDa that is probably the 480 kDa IRCP band (Figure 3).
This protein is likely to govern synthesis of the pyover-third modules of PvdI have epimerization domains that
would convert L-serine to the D-serine that is present dine chromophore [7, 8].
in pyoverdine. Furthermore, the A domains of modules
that are proposed to activate identical amino acid sub- Complementation of the pvdD Mutation
pPVDD1 that carries pvdD was tested for complementa-strates (modules 1 and 3 of PvdI [serine] and modules
4 of PvdI and 2 of PvdJ [N5-formyl-N5-hydroxyornithine]) tion of the pvdD mutation. P. aeruginosa pvdD(pPVDD1)
cells were able to synthesize pyoverdine and to groware 98% and 99% identical to one another, respectively.
Figure 3. IRCP Band Analysis
The four IRCP bands are indicated by arrows that correlate them with the genes that are thought to encode them. mut, pvdD mutant;
wt, wild-type PAO1; Ser, serine; Arg, arginine; fhOrn, N5-formyl-N5-hydroxyornithine; Thr, threonine; Glu, glutamate; Tyr, tyrosine; Dab, 2,
4-diaminobutyric acid; acyl, unusual module with high homology to acyl CoA ligases [7]; C, condensation domain; A, adenylation domain; T,
thiolation domain; TE, thioesterase domain.
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Figure 4. Spectral Analysis of pvdD::pMOD2 Cells
(A) Scanning spectrophotometric analysis. Wt pLAFR3, P. aeruginosa(pLAFR3); mut pMOD2, P. aeruginosa pvdD(pMOD2); mut pLAFR3,
P. aeruginosa pvdD(pLAFR3); mut  pMOD1, P. aeruginosa pvdD(pMOD1). The last two strains gave identical traces.
(B) MALDI-ToF analysis of pyoverdine from P. aeruginosa PAO1. The molecular mass of the major peak is indicated.
(C) MALDI-ToF analysis of pyoverdine-like compounds from supernatants of P. aeruginosa pvdD(pMOD2) cultures. The molecular mass of
each peak is indicated.
on agar containing EDDA (Table 1). They were also able P. aeruginosa pvdD carrying pMOD1 did not secrete
to support growth of a pyoverdine-deficient pvdF mutant any pyoverdine-like pigment or fluoresce under UV light,
of P. aeruginosa in cross-feeding experiments in the and these bacteria did not grow in the presence of EDDA
presence of EDDA. However, pvdD(pPVDD1) cells se- (Table 1). In contrast, P. aeruginosa pvdD(pMOD2) cells
creted less pyoverdine than wild-type bacteria (Table did secrete pigment and had some UV fluorescence
1). Spectral analysis of culture supernatants revealed (Table 1). Spectrophotometric analysis indicated that
a pyoverdine concentration of around 150 M for the the pigment secreted by these cells was similar but not
pvdD(pPVDD1) cells, compared with about 400 M for identical to wild-type pyoverdine (Figure 4A). P. aerugi-
the wild-type. nosa pvdD(pMOD2) cells were unable to grow on agar
Supernatants of cultures of wild-type P. aeruginosa containing EDDA (Table 1), indicating that the pyover-
containing pPVDD1 also contained about 150 M of dine-like pigment that was secreted was not an effective
pyoverdine, indicating that pPVDD1 reduced the amount siderophore. The pigment produced by P. aeruginosa
of pyoverdine made by the cells. This was most likely pvdD(pMOD2) was purified and analyzed by matrix-
due to overexpression of pvdD (Figure 3) resulting from assisted laser desorption ionization time-of-flight
the high copy number of the pUCP22 vector (20 to 30 (MALDI-ToF) mass spectral analysis, along with wild-type
per cell [23]). The pvdD-containing DNA fragment was pyoverdine (Figures 4B and 4C). Wild-type pyoverdine
subcloned from pPVDD1 into pLAFR3, a broad host has a molecular mass of approximately 1335 Da. The
range plasmid with a copy number of about three [24]. mass of the largest molecular species present in the
The resulting plasmid (pPVDD2) resulted in pyoverdine P. aeruginosa pvdD(pMOD2) sample was 1251 Da.
secretion at amounts comparable to wild-type levels Allowing for a 0.1% error, this is consistent with the
(around 300 M; Table 1). These results show that plas- presence of a pyoverdine that lacks a threonine residue
mid-borne pvdD can complement the pvdD mutation, (101 Da) due to the absence of a threonine-incorporating
although complementation is less effective at higher module from the pMOD2 plasmid and can no longer
gene copy number. cyclise the internal lysine side chain with the carboxyl
terminus, gaining a water equivalent (18 Da).
The P. aeruginosa pvdD(pMOD2) sample also con-Effects of Deleting a pvdD Module
tains smaller molecular species (993 and 1151 Da; FigureWe tested the effects of introducing pMOD1 (containing
4C). The 1151 Da product corresponds to the mass ofa single module of pvdD) and pMOD2 (containing a mod-
“pyoverdine” lacking both threonine residues, and theule equivalent to the second module of pvdD and the
thioesterase domain) into the P. aeruginosa pvdD mutant. 993 Da product to a “pyoverdine” lacking both threo-
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nines and also the L-N5-formyl-N5-hydroxyornithine resi- gions that are likely to be important in the overall tertiary
structure of the domain, i.e., outside  helix or  sheetdue immediately upstream. Thus, it appears that multi-
ple attenuated species of pyoverdine were present. This regions that might be disrupted by the insertion of for-
eign domain sequences (as predicted from a 3D modelconclusion is supported by the results of an HPLC amino
acid composition analysis. Wild-type pyoverdine con- based on the solved GrsA structure [5, 25]). These sites
were used to excise the native pvdD sequence and re-tained the amino acids Ser, Arg, Lys, fhOrn, and Thr in
a ratio of approximately 2:1:1:2:2, respectively, and this place it with DNA corresponding to the threonine-incor-
porating A domains from snbC of Streptomyces pris-is consistent with its structure (Figure 1). The products
purified from the P. aeruginosa pvdD(pMOD2) culture tinaespiralis and syrB of Pseudomonas syringae, a
cysteine- and a valine-incorporating A domain fromsupernatant gave an approximately 2:1:1:11/2:1/2 ratio
of the same amino acids, consistent with many of the acvA of Penicillium chrysogenum and a proposed ser-
ine-incorporating domain from the P. aeruginosa pvdImolecules lacking threonine and some of them also lack-
ing L-N5-formyl-N5-hydroxyornithine. gene (Table 2). Clustalw alignment was used to ensure
that the introduced A domains were equivalent to theWhen pMOD1 and pMOD2 were both present in the
P. aeruginosa pvdD mutant, the bacteria fluoresced un- excised regions of pvdD and would be expressed in-frame
(as illustrated for the snbC A domain in Figure 5A).der UV light and grew to a very limited extent on agar
containing EDDA (Table 1), indicating that a functional The P. aeruginosa pvdD mutant carrying the recombi-
nant plasmids was tested for the production of pyo-pyoverdine was synthesized. Culture supernatant gave
an identical spectral trace to that observed for the verdine-like compounds (Table 1). The phenotype of
P. aeruginosa pvdD(pDAX12) was indistinguishablepvdD(pMOD2) cells (Figure 4A), with elevated absorp-
tion evident in the 350–400 nm region (data not shown). from pvdD(pPVDD1) cells, indicating that the introduced
restriction sites had not impaired the function of theThe MALDI-ToF spectral trace for pigment purified from
P. aeruginosa pvdD(pMOD1/pMOD2) cells was similar pvdD gene. The presence of the threonine-incorporating
domains from S. pristinaespiralis or P. syringae alsoto that for pigment purified from the pvdD(pMOD2) strain
(Figure 4C), except that a very faint peak at 1337 Da restored pyoverdine production to pvdD mutant cells
(Table 1; Figures 5B and 5C). The pDAX12::syrB-A con-was evident, and this was consistent with low amounts
of wild-type pyoverdine being synthesized by these bac- struct was more effective than pDAX12::snbC-A in re-
storing pyoverdine production, and the levels of pyover-teria (data not shown). These results indicate that in
P. aeruginosa pvdD(pMOD1/pMOD2) the two modules dine production with either construct were significantly
lower than with pDAX12 (Figures 5B and 5C). MALDI-of PvdD expressed from the different plasmids were
capable of associating in vivo to form an active bimodu- ToF mass spectral analysis confirmed that P. aeruginosa
pvdD(pDAX12::syrB-A) produced a compound with thelar PvdD synthetase, although levels of pyoverdine pro-
duction were greatly reduced relative to wild-type. same mass as pyoverdine (Figure 5D). P. aeruginosa
pvdD(pDAX12::snbC-A) cells did not secrete sufficient
pyoverdine for MALDI-ToF analysis to be performed.
Expression of Heterologous Peptide Synthetase P. aeruginosa pvdD containing pDAX12::val-A,
Modules in the pvdD Mutant pDAX12::cys-A, or pDAX12::ser-A did not secrete any
The results described above indicate that the pyover- pyoverdine-like products or grow in the presence of
dine synthesis and secretion systems are tolerant of EDDA (Table 1). There is some evidence that C domains
quite substantial changes being introduced into the pep- contribute to the substrate selectivity of peptide synthe-
tide moiety. This suggested that the pyoverdine synthe- tase modules, displaying low selectivity for an incoming
tase system of P. aeruginosa might be a good model “donor” amino acid residue but much greater selectivity
system for carrying out domain swapping experiments for the “acceptor” residue that is activated by the A
to generate novel peptide products. The initial strategy domain of the same module [26–28]. It was therefore
employed to test this was to generate hybrid pvdD genes possible that the pDAX12::val-A, pDAX12::cys-A, and
containing A domain sequences from other peptide syn- pDAX12::ser-A constructs did not give rise to novel py-
thetase genes and determine whether these hybrid overdine products because the PvdD C domain in the
genes enabled production of pyoverdine-like molecules hybrid proteins was not compatible with the introduced
by pvdD mutant cells. A domains. To test this hypothesis, a plasmid (pDAX13)
The module chosen for alteration was the first of the was constructed to enable the introduction of heterolo-
two L-threonine activating modules of PvdD, as manipu- gous C and A domain units together into PvdD. In
lation of the second PvdD module could potentially in- pDAX13, an introduced NotI restriction site is present
hibit the activity of the associated thioesterase. Novel downstream of the A10 motif (as in Figure 5A), and an
restriction sites were engineered into pPVDD1 (giving introduced XbaI site is present just before the C1 con-
plasmid pDAX12) such that they bordered the A1 and densation motif (as defined in [29]; site [i] in Figure 1).
A10 motifs that effectively define the peptide synthetase C-A regions were exchanged into pDAX13 from the
adenylation region ([25]; Figure 1, triangles (ii) and (iii)). same genes that were used for the A domain swaps,
The criteria for selecting the locations of these sites except for syrB, which does not have a C domain.
were, first, that they be close to but outside the A1 P. aeruginosa pvdD containing pDAX13 was pheno-
and A10 motifs; second, that introduction of the novel typically identical to pvdD(pPVDD1) and pvdD(pDAX12)
restriction sequences have a minimal impact upon the (Table 1). However, none of the recombinant constructs
primary protein sequence (Figure 5A); and finally, that containing foreign CA inserts allowed P. aeruginosa
pvdD to synthesize discernible levels of fluorescent pig-the novel restriction sites not be generated within re-
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Figure 5. Strategy for Introduction of Novel
A Domains
(A) Nucleotide and protein sequence align-
ments for pvdD and snbC are shown around
the A1 sequence motif and the A10 sequence
motif. A novel XbaI site (i) was introduced
upstream of the A1 motif (boxed), and a novel
NotI site (iii) was created downstream of the
A10 motif (boxed) in pDAX12. The equivalent
regions of alternative A domains were defined
by protein and nucleotide alignment, as indi-
cated for snbC. PCR primers were designed
to amplify these regions, incorporating the
appropriate restriction sequences into the
product [as for snbC primers SnbCAUp (ii)
and SnbCADown (iv)] for cloning into
pDAX12.
(B) P. aeruginosa pvdD mutant cells con-
taining the plasmid constructs indicated,
streaked onto King’s B agar and viewed un-
der UV light.
(C) As for (A), but on King’s B agar containing
the iron-chelating agent EDDA.
(D) MALDI-ToF analysis of pyoverdine purified
from P. aeruginosa pvdD(pDAX12::SyrB-A) cul-
ture supernatant.
ment. Bacteria containing these constructs were unable with earlier findings that absolute colinearity is not es-
sential for syringomycin synthesis by P. syringae [30]to grow on agar containing EDDA (Table 1).
or surfactin synthesis by B. subtilis [31] and that four
independently purified yersiniabactin synthetase pro-Discussion
teins of Yersinia pestis can reconstitute a complete mul-
tienzyme complex in vitro [32]. Colinearity of NRPS-The purpose of the research described here was to
investigate the suitability of the pyoverdine synthesis encoding DNA with the peptide products presumably
provides a metabolic or evolutionary advantage but issystem of P. aeruginosa PAO1 for manipulation of pep-
tide synthetases and generation of novel products. To not essential for peptide synthesis.
The pvdD mutant and also the mutant containingthis end, we have shown that a mutation in the pvdD
gene can be complemented by a plasmid-borne form pMOD1 that encodes a module of PvdD did not secrete
any pyoverdine-like products, most likely because theseof pvdD and by versions of pvdD in which part of the
P. aeruginosa gene was replaced by segments of threo- strains lack the TE domain that is essential for release
of the nascent pyoverdine from the final NRPS. Likewise,nine-incorporating NRPSs from other species. Addition-
ally, the presence of only a single module of pvdD re- deletion of the surfactin synthetase TE domain pre-
vented B. subtilis from secreting surfactin [16]. It hassulted in synthesis of a form of pyoverdine from which a
threonine residue was absent. Preliminary experiments been shown that mutations in TE domains result in the
accumulation of enzyme bound peptide intermediatesinvolving the introduction of peptide synthetase do-
mains that direct the incorporation of alternative amino [33, 34].
The presence of a single module of pvdD (on plasmidacids were unsuccessful, and further research will be
required to address this issue. pMOD2) resulted in the secretion of a mixture of com-
pounds with similar spectrophotometric properties toFor most peptide synthetases, the order in which
modules are encoded in the chromosome corresponds pyoverdine but with lower molecular weights. One of
these had a mass corresponding to a form of pyoverdineto the order of amino acid residues in the peptide prod-
uct (the colinearity rule; [21, 22]), and genome analysis with only seven amino acid residues in the peptide,
lacking one of the carboxy-terminal threonines. Theindicated that the same is likely to be true for pyoverdine.
However, complementation in trans with the plasmid- smaller forms may have arisen because of excess thio-
esterase activity resulting in premature cleavage of theborne pvdD gene shows that this genomic organization
is not essential for pyoverdine synthesis. The pvdD mu- nascent pyoverdine peptide from the NRPS complex,
perhaps due to the higher copy number of the plasmidtation could also be complemented when the two mod-
ules of PvdD were encoded by fragments of pvdD that DNA relative to the chromosome, and/or the pMOD2
module lacking important structural elements for effec-were present on different plasmids. This is consistent
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Table 2. Bacteria and Plasmids Used in This Study
Strain/Plasmid Relevant Genotype and Phenotype Reference
E. coli
DH5 supE44 lacU169 (Ø80 lacZ DM5) hsdR17 a
P. aeruginosa
PAO1 wild-type Pvd b
PAO1 pvdD pvdD Pvd c
PAO1 OT11pvdF leu-1 pro-1 SmR pvdF KmR Pvd d
Plasmid
pSOT1 P. aeruginosa pyoverdine DNA in SalI site of pUC9 e
pSUP202 mobilizable ColE1 plasmid f
pDFA3 pSUP202::kanR  PstI-bordered pvdD deletion (pSOT1- c
derived)
pUCP22 lacIq lacZ(-fragment) aacC1 ColE1 ori RO1600 ori ApR GmR g
pPVDD1 pUCP22  Bam-Sal pvdD ex pSOT1 c
pLAFR3 cos mob TcR h
pPVDD2 pLAFR3  Bam-Sal pvdD ex pSOT1 c
pPROEX1::mod1 lacIq ori ApR pTrc pvdD(module 1) i
pSF2 pGEM-T (Promega) containing oriT and rep ApR j
pMOD1 pPROEX1::mod1  mob (ex pSF2) c
pUC18Sma pUC18 lacking SmaI, KpnI, and SstI sites from the MCS c
pUC18Sma::pvdD pUC18Sma  Bam-Sal pvdD ex pSOT1 c
pMOD2 pPVDD1 (single pvdD module deletion) c
pDAX10 pUC18Sma::pvdD-derivative c
pDAX11 pDAX10-derivative c
pDAX12 pPVDD1(Xba/Not flanking Adom1) A domain swapping vector c
pVRC1210 T7-RNA polymerase-based expression vector  snbC ApR k
pPEN510 pUC19 carrying the acvA synthetase gene l
pYM101 pUC19 carrying the syrB,C,D gene cluster m
pDAX12::cys-A pDAX12  acvA (mod2; cys-specifying) mod1 A domain swap c
pDAX12::ser-A pDAX12  pvdI (mod1; ser-specifying) mod1 A domain swap c
pDAX12::snbC-A pDAX12  snbC (mod1; thr-specifying) mod1 A domain swap c
pDAX12::syrB-A pDAX12  syrB (mod9; thr-specifying) mod1 A domain swap c
pDAX12::val-A pDAX12  acvA (mod3; val-specifying) mod1 A domain swap c
pDAX13 pPVDD1(Xba/Not flanking CAdom1) CA-swapping vector c
pDAX13::cys-CA pDAX13 acvA (mod2; cys-specifying) mod1 CA domain swap c
pDAX13::ser-CA pDAX13  pvdI (mod1; ser-specifying) mod1 CA domain swap c
pDAX13::snbC-CA pDAX13  snbC (mod1; thr-specifying) mod1 CA domain swap c
pDAX13::val-CA pDAX13  acvA (mod3; val-specifying) mod1 CA domain swap c
References: a, GIBCO BRL; b, [42]; c, this study; d, [46]; e, [20]; f, [47]; g, [23]; h, [24]; i, [5]; j, H.P. Schweizer; k, [48]; l, [49]; m, [50].
tive association with the upstream synthetase PvdJ. Al- production, despite this domain having greater similarity
to the PvdD A domain than SyrB (54% identity and 75%ternatively, the single-threonine form of pyoverdine is
not cyclised and consequently may be susceptible to similarity for SnbC/PvdD as opposed to 38% identity
and 68% similarity for SyrB/PvdD as determined byspontaneous or proteolytic cleavage of amino acid resi-
dues from the carboxy terminus. Minimal module substi- Clustalw alignment). These results indicate that peptide
synthetase modules with very strong sequence similar-tutions at position 2 of the surfactin synthetase complex
gave rise to multiple surfactin-like products, the size ity that activate the same amino acid substrate may
nonetheless act in slightly different fashions.of these products being consistent with one or more
residues having been lost from the surfactin peptide However, recombinant constructs designed to incor-
porate alternative residues into the pyoverdine peptidechain [14]. Thus, it must be considered that manipulation
of peptide synthetase templates may result in the gener- (pDAX12::cys-A, pDAX12::val-A, and pDAX12::ser-A)
failed to restore pigment production to pvdD mutantation of inherently unstable peptide products. The
pvdD(pMOD2) cells secreting the attenuated forms of cells. This was most likely due to one or more of the
following: failure of the introduced A domains to activatepyoverdine were unable to grow on agar containing
EDDA, indicating that these compounds could not act an amino acid substrate; inability of the introduced A
domains to interact effectively with the PvdD T domain;as siderophores. It remains to be determined whether
these compounds were unable to chelate Fe3 ions or or inability of the PvdD C domain to catalyze peptide
bond formation between the incoming L-N5-formyl-N5-whether P. aeruginosa lacks the ability to take up the
resulting complexes. hydroxyornithine and the novel residue activated by the
introduced A domains.pvdD mutant cells containing versions of pvdD in
which the A domain of module 1 was replaced by the The last possibility was considered the most likely,
as there is some evidence that C domains display selec-A domains of two threonine-incorporating NRPSs from
other species produced functional pyoverdine, although tivity for the residue activated by the A domain immedi-
ately downstream [26, 27]. This proposal initially ap-in lower amounts than obtained with native pvdD. The
SnbC A domain gave the lower amounts of pyoverdine pears to conflict with the successful results of the AT
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domain swaps for the B. subtilis surfactin synthetase T domains may also play a role in determining the sub-
strate specificity of an individual module, and the intro-system [13, 14]. However, for both studies, the recombi-
nant synthetases exhibited markedly decreased rates of duced CA sequences may have been incompatible with
the native PvdD T domain. It has been shown that thelipopeptide biosynthesis, suggesting that “intermodular
interactions might be disturbed” [14]. Later, the same phosphopantetheinylated T domain of the valine-acti-
vating SrfB1 module of surfactin synthetase could begroup proposed that an editing function of the C do-
mains might have promoted an incompatibility of the C aminoacylated by the cognate A domain but not by the
aspartic acid-activating A domain of SrfB2 [36]. Further-and A domains in their artificial junctions, explaining
why the reported fusions had decreased activity and more, in sequence alignments, unrelated T domains
show a degree of clustering according to the amino acidwhy other fusion constructs had displayed no activity
at all [35]. The yield of recombinant surfactin was signifi- substrate that is activated by their associated A domain
[27]. It has also been proposed that, rather than directcantly increased by carrying out domain swaps that
included a section of C domain as well as the AT do- substrate recognition by T domains, there may be an
optimal interaction between paired A and T domainsmains swapped previously [15].
To allow for possible C domain incompatibility, hybrid such that the 4-PP cofactor bound to a given T domain
may have greater accessibility to the residue activatedgenes were constructed in which the CA domains of the
first module of PvdD were replaced by the CA domains by a native A domain partner than a nonnative A domain
partner [37]. This may be one explanation for SnbC beingof other peptide synthetases. However, none of the CA
hybrid genes, including one (pDAX13::snbC-CA) con- less effective than SyrB at replacing the PvdD A domain,
despite its greater shared amino acid identity. Likewise,taining a threonine-incorporating A domain, restored
production of pyoverdine-like compounds to the pvdD suboptimal T domain interactions may have contributed
to the failure of the CA-swapping experiments describedmutant. This indicates that, at least for snbC, introduc-
tion of a novel C domain actually inhibited pyoverdine in this paper.
Thus, there are two likely reasons why the CA-swap-synthesis. One explanation is that C domains may not
only display selectivity for cognate acceptor residues ping strategy might have proved unsuccessful. Each of
these reasons is also compatible with the observationsbut also for donor residues, and the SnbC C domain
was unable to utilize the incoming L-N5-formyl-N5-hydro- made for the A domain swapping experiments. The
“suboptimal T domain interaction” hypothesis would ex-xyornithine substrate provided by the pyoverdine syn-
thetase system. Sequence alignments [27] indicate that plain why foreign A domain hybrids recognizing the
same amino acid substrate produced different levels ofC domains do cluster according to donor-residue speci-
ficity. Alignment of pyoverdine peptide synthetase C pyoverdine, and the “C domain donor residue specific-
ity” hypothesis would explain why these hybrid modulesdomain sequences (data not shown) also support this
still managed to produce some pyoverdine, as opposedproposal: the two L-N5-formyl-N5-hydroxyornithine acti-
to the CA domain hybrids. The original “C domain ac-vating modules are 99% identical across their A domain
ceptor residue specificity” hypothesis of Belshaw et al.sequences but only 26% identical across their C do-
[26] then completes the picture, explaining why none ofmains; whereas the first of these modules shares 58%
the constructs carrying A domains of altered specificityidentity across the C domain region with the L-arginine
were able to restore pigment production to the pvdDactivating module of PvdI, these latter two domains both
mutant cells.receiving an incoming D-serine donor residue. Neither
of these C domains have more than 28% identity with
Significanceany of the pyoverdine synthetase C domains that are
predicted to receive L-amino acid donor residues. Fur-
So far as we are aware, this work is the first report ofthermore, the C domains of the first module of PvdD and
the specific modification of a nonribosomally synthe-the first module of PvdJ, which both receive incoming
sized peptide in vivo outside of B. subtilis. The demon-L-N5-formyl-N5-hydroxyornithine donor residues, are
strated ability of modified pyoverdines to be secreted70% identical with one another. The successful domain
and readily purified as clearly visible pigments, cou-swaps that included sections of C domains as well as
pled with the availability of a plasmid-borne comple-the AT domain regions [15] do not preclude C domains
mentation system, suggests that the pyoverdine syn-having a proofreading activity. The foreign lichenysin
thetases of P. aeruginosa may provide an excellentsynthetase modules from B. licheniformis that were in-
model system for studying domain and module swap-troduced into the surfactin synthetases in B. subtilis
ping of peptide synthetase enzymes. Plasmid-basedaccept identical donor residues to the original surfactin
expression will greatly facilitate the engineering ofmodules. Also, C domain regions that confer acceptor
modified synthetase genes and will enhance the feasi-residue specificity may be located downstream of the
bility of ultimately establishing combinatorial peptideHHxxxDG swap site used previously [15], while those
synthetase libraries [38, 39]. It will also facilitate furtherthat define donor residue specificity may be upstream
research aimed at identifying the precise parametersof this site at the N terminus of a C domain. This is
that enable engineered hybrid synthetases to be fullyconsistent with domain organization in PvdD; a dispro-
active.portionate 54 of the 105 nonidentical residues in the 430
residue C domains of the two PvdD modules are within
Experimental Proceduresthe first 120 amino acids of their primary sequences.
A second possible reason for the failure of the CA- Bacterial Strains, Plasmids, Chemicals, and Media
hybrid genes (and the altered-specificity A domain hy- The bacterial strains and plasmids employed in this study are listed
in Table 2. Escherichia coli was grown in Luria broth (LB; GIBCObrids) to give rise to pyoverdine-like compounds is that
NRPS Domain Swapping in P. aeruginosa
979
BRL). P. aeruginosa was cultured in Brain Heart Infusion broth (BHI; Received: November 13, 2003
Revised: April 27, 2004GIBCO BRL) or in King’s B broth [40] or succinate medium [41] for
iron-limited conditions. Plates were prepared with 1.5% (w/v) agar Accepted: April 28, 2004
Published: July 23, 2004(GIBCO BRL). Ethylene-diamine-di(o-hydroxyphenylacetic acid)
(EDDA) and antibiotics were used at the same concentrations as
previously [6, 46].
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